Bibliographic Citation
| Document | For copies of Journal Articles, please contact the Publisher or your local public or university library and refer to the information in the Resource Relation field. For copies of other documents, please see the Availability, Publisher, Research Organization, Resource Relation and/or Author (affiliation information) fields and/or Document Availability. |
|---|---|
| Title | Radioiodine-induced thyroid storm. Case report and literature review |
| Creator/Author | McDermott, M.T. ; Kidd, G.S. ; Dodson, L.E. Jr. ; Hofeldt, F.D. |
| Publication Date | 1983 Aug 01 |
| OSTI Identifier | OSTI ID: 5545019 |
| Other Number(s) | Journal ID: CODEN: AJMEA |
| Resource Type | Journal Article |
| Resource Relation | Journal Name: Am. J. Med.; (United States); Journal Volume: 75:2 |
| Research Org | Endocrinology and Metabolism Service, Fitzsimons Army Medical Center, Aurora, Colorado |
| Subject | 63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.; 62 RADIOLOGY AND NUCLEAR MEDICINE; CALCIUM; BLOOD CHEMISTRY; TOXICITY; HYPERTHYROIDISM; RADIOTHERAPY; SIDE EFFECTS; ADENOMAS; IODINE ISOTOPES; MALES; PATIENTS; PITUITARY GLAND; REVIEWS; THYROID; ALKALINE EARTH METALS; BODY; DISEASES; DOCUMENT TYPES; ELEMENTS; ENDOCRINE DISEASES; ENDOCRINE GLANDS; GLANDS; ISOTOPES; MEDICINE; METALS; NEOPLASMS; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY |
| Description/Abstract | Thyroid storm developed following radioiodine therapy in a 43-year-old man with Graves' disease, weight loss, myopathy, severe thyrotoxic hypercalcemia, and a pituitary adenoma. The hypercalcemia may have been a significant, and previously unreported, predisposing factor for the radioiodine-associated thyroid storm. This case and 15 other well-documented cases of radioiodine-associated storm found in the literature are reviewed, as are several other cases of less severe exacerbations of thyrotoxicosis associated with radioiodine therapy. Although not often seen, these complications are often fatal. High-risk patients, such as the elderly, those with severe thyrotoxicosis, and those with significant underlying diseases, may benefit from preventive measures such as the judicious use of thyrostatic medications during the periods before and after isotope administration. |
| Country of Publication | United States |
| Language | English |
| Format | Medium: X; Size: Pages: 353-359 |
| System Entry Date | 2009 Dec 16 |
Top | |